Why is Kwality Pharma falling/rising?

As of 07-Jul, Kwality Pharmaceuticals Ltd is currently priced at Rs. 1,162.00, reflecting a decrease of Rs. 14.95 or 1.27%. The stock recently hit a new 52-week high of Rs. 1,235 but has since fallen after five consecutive days of gains. Despite this recent decline, the stock has shown strong performance over various periods, with a 1-week return of 9.58%, a 1-month return of 25.08%, and a remarkable 129.24% return over the past year. However, the stock underperformed its sector by 1.19% today, and there has been a significant drop in investor participation, with delivery volume falling by 45.24% against the 5-day average. While the company has demonstrated strong financial metrics, including a low Debt to EBITDA ratio and impressive profit growth, it also faces challenges such as declining net sales and operating profit over the past five years, which may contribute to the recent price movement.
In the broader market context, Kwality Pharmaceuticals has outperformed the Sensex, which has seen a slight decline of 0.20% over the past week, while Kwality's stock has risen by 9.58%. This indicates that the stock's recent performance is strong relative to the market. However, the stock's current price drop may reflect profit-taking after reaching a high, alongside concerns about its long-term growth potential, as indicated by the negative trends in net sales and operating profit. The lack of domestic mutual fund investment may also signal caution among institutional investors regarding the stock's valuation and future prospects.